| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0005100 | Exon-Exon | chr4:144459939-144468061 | chr4:143538786-143546908 | 1036 nt | 0.3929 |
| hsa_SMARCA5_0005900 | Intron-Exon-Intron | chr4:144464632-144465125 | chr4:143543479-143543972 | 299 nt | 0.3645 |
| hsa_SMARCA5_0006000 | Exon-Exon | chr4:144464662-144464810 | chr4:143543509-143543657 | 149 nt | 0.3893 |
| hsa_SMARCA5_0006100 | Exon-Exon | chr4:144464662-144465125 | chr4:143543509-143543972 | 269 nt | 0.3792 |
| hsa_SMARCA5_0006200 | Exon-Exon | chr4:144464662-144466000 | chr4:143543509-143544847 | 380 nt | 0.3947 |
| hsa_SMARCA5_0007700 | Exon-Exon | chr4:144467114-144468021 | chr4:143545961-143546868 | 180 nt | 0.3444 |
| hsa_SMARCA5_0001100 | Exon-Exon | chr4:144445520-144445620 | chr4:143524367-143524467 | 101 nt | 0.4455 |
| hsa_SMARCA5_0001200 | Exon-Exon | chr4:144445520-144449867 | chr4:143524367-143528714 | 670 nt | 0.3761 |
| hsa_SMARCA5_0001300 | Exon-Exon | chr4:144445520-144451679 | chr4:143524367-143530526 | 739 nt | 0.3789 |
| hsa_SMARCA5_0001900 | Exon-Exon | chr4:144446604-144451679 | chr4:143525451-143530526 | 638 nt | 0.3683 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].